MASH is a chronic and progressive liver disease characterised by fat accumulation and inflammation in the liver,
Almost 300 million people globally have chronic hepatitis B
Six engaging sessions focusing on Prevention of Kidney Diseases, Brain Stem Death Declaration, Deceased Donor Management, Prevention of Liver Diseases, Legal Aspects of Organ and Tissue Donation, Eye Donation and Corneal Transplant held as part of the Webinar
The primary endpoint is to measure the change in liver stiffness measurement performed by transient elastography from Baseline to Week 52
Tremelimumab in combination with Durvalumab is indicated for the treatment of patients with unresectable hepatocellular carcinoma (uHCC)
Collaboration will enable rapid advancement of a joint preclinical proof of concept program for type 1 diabetes
The proposed initiative is conceptualised with an objective to identify, support, and promote innovative research ideas in healthcare research
China has the highest number of clinical trials that were initiated in NAFLD in the APAC region over the past decade.
Saroglitazar Mg is an investigational compound in the USA/EU, undergoing Phase 2b/3 clinical trials in patients with Primary Biliary Cholangitis and Phase 2b in patients with Non- alcoholic Steatohepatitis
Approval based on HIMALAYA Phase III trial results which showed single priming dose of Imjudo added to Imfinzi reduced risk of death by 22% vs. sorafenib
Subscribe To Our Newsletter & Stay Updated
